- Summits
- Sponsorship
- Media Opportunities
- News
- About
Charlottesville-based Icarus Medical has announced the successful close of a $7.2 million Series A financing round, surpassing its original target of $5 million. The oversubscribed raise reflects growing investor confidence in the company’s orthopedic bracing technology, commercial progress, and long-term growth strategy.
The funding will support several key initiatives, including accelerated commercialization across the United States, continued product development, manufacturing expansion, clinical validation of existing technologies, and workforce growth as the company strengthens its national footprint.
The round attracted participation from a group of healthcare-focused investors, including Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors. Beyond capital, these investors bring expertise in healthcare, commercialization, operations, and strategic partnerships that are expected to support the company’s next phase of growth.
“This financing represents a major milestone for Icarus Medical and validates both the clinical impact of our technology and the strength of the team we have built,” said Dave Johnson, Founder and CEO of Icarus Medical.
“We are excited to partner with investors who not only believe in our mission, but who also bring strategic insight and relationships that can help accelerate our trajectory.”
Founded in Charlottesville, Virginia, Icarus Medical is developing orthopedic bracing technologies that combine biomechanics, additive manufacturing, and patient-centered design. The company aims to help individuals remain active and mobile while reducing pain and improving function.
Its portfolio includes the Ascender Knee Brace, designed for patients with patellofemoral and multicompartment osteoarthritis, as well as solutions that support post-operative recovery, neurological conditions, and complex lower-extremity mobility challenges.
Investor interest in the company reflects growing recognition of the need for innovative approaches to musculoskeletal care. According to OSF Ventures, clinical feedback played an important role in its investment decision.
“Our health system’s mission is to serve all persons with the greatest care and love. As we evaluated Icarus Medical, we needed to be confident that its solutions could meaningfully improve the lives of the patients we serve,” said Ben Spektor, Director of Venture Investments at OSF Ventures.
“Through engagement with our clinicians, we quickly validated that conviction and received strong feedback regarding both the significant unmet need and the value of Icarus’ innovative bracing technology. Icarus is at the forefront of bracing innovation, and we are proud to support the company’s growth while helping expand access to its products across our Ministry.”
The company designs and manufactures its products in Charlottesville and continues to invest in expanding its manufacturing capabilities while creating new local employment opportunities.
Over the past year, Icarus Medical has also received recognition for its growth trajectory. The company was named to the Inc. 5000 list of America’s fastest-growing private companies after achieving 1,283% growth over three years. It was also awarded the 2026 CBIC Startup of the Year Award by the Charlottesville Business Innovation Council.
Looking ahead, Johnson believes the combination of financial backing and strategic expertise will help position the company for continued expansion.
“Healthcare innovation requires more than just great technology. It requires strong clinical alignment, operational execution, and the ability to scale,” he said. “We believe this group of investors positions us extremely well for the next phase of the company.”
MedTech World is coming to Hong Kong from 26 to 28 August. The event will bring together startups, investors, healthcare leaders, and industry stakeholders to discuss the latest developments in medical technology, investment, commercialization, and global market expansion. Learn more and secure your place today.
